AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
NIMODIPINE
24 registrations across 7 African markets— 23 active
Markets with NIMODIPINE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Nimotop tablets 30 mg Tablet | 🇰🇪Kenya | Bayer Pharma AG | active | Jul 2031 |
| NIMOTOP SOLUTION FOR INFUSION (Each bottle with solution for infusion contains Nimodipine 10mg in 50 ml alcohol solvent.) | 🇬🇭Ghana | — | active | Feb 2031 |
| NIMOTOP SOLUTION FOR INFUSION (Each bottle with solution for infusion contains Nimodipine 10mg in 50 ml alcohol solvent.) | 🇬🇭Ghana | — | active | Feb 2031 |
| NIMOTOP TABLETS | 🇬🇭Ghana | — | active | Feb 2030 |
| NIMOTOP TABLETS | 🇬🇭Ghana | — | active | Feb 2030 |
| NIMOTOP IV SOLUTION; INFUSION | 🇿🇼Zimbabwe | BAYER (PTY) LTD | active | Dec 2027 |
| NIMOTOP TABLET, COATED; ORAL | 🇿🇼Zimbabwe | BAYER (PTY) LTD | active | Dec 2027 |
| ASPEN NIMODIPINE IV | 🇿🇦South Africa | ACINO PHARMA (PTY) LTD | suspended | Dec 2023 |
| NIMOTOP IV | 🇿🇦South Africa | Bayer (Pty) Ltd û Isando | active | Jan 1900 |
| NIMODIPINE PARENTERAL
ORDINARY I V VIALS | 🇺🇬Uganda | BAYER PHARMA AG | active | — |
| NIMOTOP SOLUTION POUR PERFUSION | 🇲🇦Morocco | — | active | — |
| MODINE COMPRIME ENROBE | 🇲🇦Morocco | — | active | — |
| MODINE SOLUTION INJECTABLE POUR PERFUSION | 🇲🇦Morocco | — | active | — |
| NIMODIPINE ORAL SOLID
ORDINARY FILM-
COATED
TABLETS | 🇺🇬Uganda | BAYER PHARMA AG | active | — |
| NIMODIPINE PARENTERAL
ORDINARY I V
VIALS | 🇺🇬Uganda | BAYER PHARMA AG | active | — |
| NIMODIPINE ORAL SOLID
ORDINARY FILM-
COATED TABLETS | 🇺🇬Uganda | BAYER PHARMA AG | active | — |
| MODINE COMPRIME ENROBE | 🇲🇦Morocco | — | active | — |
| NIMODIPINE ORAL SOLID
ORDINARY FILM-
COATED TABLETS | 🇺🇬Uganda | BAYER PHARMA AG | active | — |
| NIMODIPINE PARENTERAL
ORDINARY I V VIALS | 🇺🇬Uganda | BAYER PHARMA AG | active | — |
| NIMODIPINE ORAL SOLID
ORDINARY FILM-
COATED
TABLETS | 🇺🇬Uganda | BAYER PHARMA AG | active | — |
| Nimotop Infusion | 🇹🇿Tanzania | Bayer East Africa Ltd | active | — |
| NIMODIPINE PARENTERAL
ORDINARY I V
VIALS | 🇺🇬Uganda | BAYER PHARMA AG | active | — |
| MODINE SOLUTION INJECTABLE POUR PERFUSION | 🇲🇦Morocco | — | active | — |
| Nimotop Tablets | 🇹🇿Tanzania | Bayer East Africa Ltd | active | — |
NIMODIPINE in Africa — Regulatory Overview
NIMODIPINE is registered across 7 African markets with 24 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Uganda, Morocco, Ghana, Tanzania and 3 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 24 registrations, 23 (96%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.